Pfizer CEO Dr. Albert Bourla on the decision for mRNA vaccines and how they'll handle new Covid variants

During a special edition of Leadership Matters, host Alan Fleischmann speaks with CEO of Pfizer Dr. Albert Bourla about the choice to pursue mRNA Covid vaccines, a new technology outside their expertise. He also details how mRNA vaccines will address new Covid variants in the future.